Andrew J. Cutler, MD: Screening Techniques for ADHD

Video

Attempts to use neuroimaging to screen for ADHD in the past have failed.

Screening for attention deficit/hyperactivity disorder (ADHD) has not changed much over the years.

Often the screening practices include a self-screening questionnaire to help the patient recognize the signs and symptoms of ADHD. For adolescent ADHD patients, the screening process can also include interviews from teachers, family members, and other people.

While there are tools to help the psychiatry screen patients for the disorder, a high degree of suspicion remains the most important aspect of screening for ADHD.

Doctors will look to find out not only about the individual symptoms each patient must have, but also how these symptoms might impact their lives. For example, ADHD is known to have an impact on an individual’s school or work function, so to be diagnosed and treated for ADHD most patients can readily have an example of how those functions have been impacted.

In an interview with HCPLive®, Andrew, J. Cutler, MD, Clinical Professor of Psychiatry at SUNY Upstate Medical University, explained why screening practices are effective and why there is some hope for new techniques and technologies to make an impact in the future.

Cutler said right now there is no biomarkers or clinically relevant sensitivity testing useful and accurate enough to be used on the widescale for ADHD.

Recent Videos
Arshad Khanani, MD: Four-Year Outcomes of Faricimab for DME in RHONE-X | Image Credit: Sierra Eye Associates
Dilraj Grewal, MD: Development of MNV in Eyes with Geographic Atrophy in GATHER | Image Credit: Duke Eye Center
Margaret Chang, MD: Two-Year Outcomes of the PDS for Diabetic Retinopathy | Image Credit: Retina Consultants Medical Group
Carl C. Awh, MD: | Image Credit:
Raj K. Maturi, MD: 4D-150 for nAMD in PRISM Population Extension Cohort | Image Credit: Retina Partners Midwest
Charles C. Wykoff, MD, PhD: Interim Analysis on Ixo-Vec Gene Therapy for nAMD | Image Credit: Retina Consultants of Texas
Sunir J. Garg, MD: Pegcetacoplan Preserves Visual Function on Microperimetry | Image Credit: Wills Eye Hospital
Edward H. Wood, MD: Pharmacodynamics of Subretinal RGX-314 for Wet AMD | Image Credit: Austin Retina Associates
Dilsher Dhoot, MD: OTX-TKI for NPDR in Interim Phase 1 HELIOS Results  | Image Credit: LinkedIn
Katherine Talcott, MD: Baseline EZ Integrity Features Predict GA Progression | Image Credit: LinkedIn
© 2024 MJH Life Sciences

All rights reserved.